Beyond ATTR in Japan: Accurate diagnosis of cardiac AL in the TTR stabilizer era (in Japanese)

touchEXPERT FOCUS for touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY

Listen to a series of interviews with Dr. Toru Kubo as he shares his expert insights into real-world diagnostic pitfalls in cardiac amyloid light-chain amyloidosis (AL), stepwise application of the Japanese Circulation Society (JCS) diagnostic algorithm to achieve an accurate diagnosis of cardiac AL, and timely engagement of hematology and multidisciplinary discussion around transthyretin (TTR) stabilizer initiation.

The expert:

• Dr. Toru Kubo, Kochi Medical School, Kochi University, Japan

This touchPODCAST is recorded in Japanese and is intended for HCPs in Japan.

This activity is funded by an independent medical education grant from Alexion Pharma GmbH.

This activity is jointly provided by Partners for Advancing Clinical Education and touchIME.

For further information, please visit our websites: touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY